Rivas Medical Weight Loss Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.7/10
Best for: MD/VA/FL patients wanting hands-on weekly in-person or telehealth GLP-1 visits
Rivas Medical Weight Loss is a solid telehealth option with balanced features and pricing.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Not disclosed
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
Rivas Medical Weight Loss is a physician-founded program (Paul Rivas MD LLC) combining 15 in-person clinics with telehealth across Maryland, Virginia, and Florida. It offers compounded semaglutide at $115/week and compounded tirzepatide at $165/week, flat for any dose, with each all-inclusive weekly price covering the medication plus a provider visit. The concierge weekly-visit model runs higher than mail-order competitors.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Rivas Medical Weight Loss
MEDVi
Best for: patients who want the option to switch between compounded and brand-name GLP-1 through one provider
Editorial score · methodology
Liv Body
Best for: compounded GLP-1 paired with a muscle-preservation supplement stack
Editorial score · methodology
DudeMeds
Best for: men seeking no-fee GLP-1 access with oral and injectable options
Editorial score · methodology
Rivas Medical Weight Loss at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $498/mo (billed $115/week for any dose; all-inclusive (visit + medication); ~$498/mo equivalent)
- Pricing model
- Flat — dose increases don't raise the monthly price
- What's included
- Medication · Consult
- Availability
- 3 states
- FDA status
- No FDA warning letter on record
How we scored Rivas Medical Weight Loss
Each dimension is scored algorithmically from Rivas Medical Weight Loss’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
5.6/10At $498/mo, Rivas Medical Weight Loss runs about 195% above the $169 median for GLP-1 providers. Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
7.8/10Rivas Medical Weight Loss offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.1/10Online intake and platform experience — consult included in the price; 6 platform features disclosed.
Trust & Safety15%
7.8/10Key details fully confirmed by our editors; no FDA warning letters on file (last checked 2026-07-16).
Accessibility10%
5.3/10Rivas Medical Weight Loss operates in a limited 3-state footprint — check availability first.
Support10%
5.6/10Rivas Medical Weight Loss provides standard clinician follow-up; no extended coaching or community program is disclosed.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Rivas Medical Weight Loss review
Last checked July 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed availability in 3 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: high.
GLP-1 medications Rivas Medical Weight Loss offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
billed $115/week for any dose; all-inclusive (visit + medication); ~$498/mo equivalent
billed $165/week for any dose; all-inclusive (visit + medication); ~$715/mo equivalent
Ready to get started?
Plans and promotions change often — check Rivas Medical Weight Loss's current pricing and active discounts before you decide.
What we like
- Physician-founded (Paul Rivas MD) with 15 clinics plus telehealth
- Flat price for any dose; weekly provider visits included in every payment
- Offers both compounded semaglutide and tirzepatide
Watch-outs
- Expensive: about $498/mo for semaglutide and $715/mo for tirzepatide (billed weekly)
- Only available in Maryland, Virginia, and Florida
- Weekly-visit concierge model requires more frequent engagement than mail-order
Is Rivas Medical Weight Loss worth it? Our verdict
Rivas Medical Weight Loss positions itself around one thing: MD/VA/FL patients wanting hands-on weekly in-person or telehealth GLP-1 visits. It runs $498/month, flat across every dose — a premium to the category, so the extras need to justify it. Its flat, all-dose pricing is a genuine plus for anyone worried about cost climbing as they titrate up.
Beyond the core GLP-1 program, Rivas Medical Weight Loss leans on Weekly Visits, In-Person + Telehealth, and Flat Dose Pricing.
How much Rivas Medical Weight Loss actually costs
- Compounded semaglutide — $498/month
- Compounded tirzepatide — $715/month
For context, the typical ongoing price across the GLP-1 providers we track is around $169/month, so Rivas Medical Weight Loss's standing rate sits at the premium end.
For a direct comparison, MyStart Health runs semaglutide and tirzepatide from $299/month — worth pricing against Rivas Medical Weight Loss before you commit.
Medications: what Rivas Medical Weight Loss prescribes
Rivas Medical Weight Loss prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes. The medication is compounded at a licensed pharmacy rather than sold as a brand pen, which is what keeps the price down. The trade-off is the one every compounded provider shares: compounded drugs aren't FDA-approved as finished products.
Who Rivas Medical Weight Loss is best for — and who should skip it
A good fit if you…
- want a straightforward telehealth GLP-1 program.
Look elsewhere if you…
- want the lowest total cost over 6–12 months — a flat-rate provider like bmiMD will likely beat the ongoing price.
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
Rivas Medical Weight Loss is available in 3 states. We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
Rivas Medical Weight Loss costs more than the budget end of the market, so it makes the most sense if its specific extras matter to you. If they don't, you can likely get the same medication for less elsewhere.
The Bottom Line
Rivas Medical Weight Loss is a solid telehealth option with balanced features and pricing.
Ready to start with Rivas Medical Weight Loss?
Starting at $498/month. See current pricing and start your free consultation.
Rivas Medical Weight Loss might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
- If the lowest possible monthly price is your top priority, consider Sesame Care (from $59/mo).
- If you want built-in coaching and behavior-change support, consider MEDVi.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Rivas Medical Weight Loss review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Rivas Medical Weight Loss's current pricing
Plans start at $498/month. Start your free consultation to check eligibility and today's price.